A few days ago I was privileged and delighted to be invited to attend a dinner hosted by the Australian Self Medication Industry (ASMI) in honour of Juliet Seifert. Juliet was the Executive Director of ASMI from 1998 to 2010.

Juliet’s contribution to ASMI over that period has been enormous, and as many of the distinguished speakers on the evening said in celebration of her achievements, her positive contributions to the development of health policy in Australia extended far beyond her specific role as an advocate for ASMI. Indeed, it would be true to say that Juliet has been an advocate for all interested in better health: consumers, professions, research, industry, and government.

I have had the great pleasure of participating in a number of health policy initiatives in which Juliet successfully achieved a remarkably collaborative approach among all the participants in the interests of the common good. I could say a great deal more, but others, far more qualified than I, have spoken on this subject and will undoubtedly do so in the future.

But I couldn’t let the moment pass without celebrating Juliet’s contribution to CRI. Since the mid-1990s to 2008, Juliet was a Member of our Board of Governors and a Member of the Board’s Executive Committee. In that capacity, Juliet guided our research and advisory agenda and acted as a wonderfully astute friend and mentor to CRI. Like all our Board Members, Juliet did this work in a voluntary capacity for the common good. We thank her greatly.

In a future blog I will mention some of the remarkable evidence of Juliet’s contribution.